跳至主要内容
临床试验/EUCTR2020-001155-40-DK
EUCTR2020-001155-40-DK进行中(未招募)1 期

Kidney Fat in Type 2 Diabetes & Diabetic Kidney Disease and the Effects of Ezetimibe: A Cross-Sectional Study and Randomized, Placebo-Controlled Trial - DiaKiDZ

Steno Diabetes Center Copenhagen0 个研究点目标入组 120 人开始时间: 2020年4月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Main eligibility criteria for control group (cross-sectional study alone):
  • No diabetes mellitus
  • No kidney disease or urinary albumin creatinine ratio = 30mg/g
  • No contraindication to examination by magnetic resonance
  • Main eligibility criteria for control group (cross-sectional study alone):
  • Age 40-80 years
  • No diabetes mellitus
  • No kidney disease or urinary albumin creatinine ratio = 30mg/g
  • No contraindication to examination by magnetic resonance
  • Main eligibility criteria for group of individuals with type 2 diabetes and no diabetic kidney disease (cross-sectional study alone):
  • Age 40-80 years
  • Type 2 diabetes
  • No kidney disease or urinary albumin creatinine ratio = 30mg/g
  • No contraindication to examination by magnetic resonance
  • Main eligibility criteria for group of individuals with type 2 diabetes and non-severe diabetic kidney disease (intervention trial):
  • Age 40-80 years
  • Type 2 diabetes
  • Estimated glomerular filtration rate =30ml/min/1,73m2
  • Urinary albumin creatinine ratio = 30mg/g
  • No contraindication to examination by magnetic resonance
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • Please refer to E.3

研究者

相似试验